The health technology assessed is a non-invasive device for the early detection of colorectal cancer that supplements the established fecal occult blood tests with the stool-based analysis of tumor DNA. The objective of this assessment was to evaluate whether Stool DNA testing (alone or in addition to occult blood testing) in adult patients from a colorectal cancer screening population is more effective and/or safer than other available colorectal cancer screening tests